Day: May 13, 2022

SAN DIEGO — Liver fat content is not associated with risk for any cardiovascular event, according to data from the Dallas Heart Study presented at the AACE Annual Scientific and Clinical Conference.“Because of the high prevalence of CV events in patients with nonalcoholic fatty liver disease (NAFLD), we expected to see an association between liver…

SAN DIEGO — Higher sex hormone-binding globulin levels may predict liver fibrosis for men with nonalcoholic fatty liver disease, according to a presenter at the AACE Annual Scientific and Clinical Conference.In a study analyzing a cohort of men with known nonalcoholic fatty liver disease (NAFLD), median SHBG levels were higher among men with a high…

Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing.“NAFLD in lean individuals is not a benign disease,” Karn Wijarnpreecha, MD, MPH, a transplant hepatology fellow at the University of…

Between 2012 and 2019, esophageal cancer rates nearly doubled and prevalence of Barrett’s esophagus increased by 50% among adults aged 45 to 64 years, according to researchers.“Esophageal cancer, unfortunately, is often a silent killer — there are minimal symptoms usually until somebody has advanced disease,” Bashar J. Qumseya, MD, MPH, FASGE, associate professor of medicine…

Sun Pharmaceutical Industries received FDA approval of its abbreviated new drug application for mesalamine extended-release capsules indicated for use in ulcerative colitis, according to a press release.The FDA determined that, among adult patients with mildly to moderately active UC, Sun Pharmaceutical’s 500 mg product is therapeutically equivalent to Ferring Pharmaceuticals’ Pentasa 500 mg extended-release capsule,…